| Zhu, Jianqing |
NCT02859038: Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) |
|
|
| Recruiting | 3 | 488 | RoW | Upfront cytoreductive surgery, Primary debulking surgery, PDS, Interval debulking surgery, NACT-IDS | Shanghai Gynecologic Oncology Group | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma | 06/23 | 06/23 | | |
FZPL-II-201, NCT04517357: A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients |
|
|
| Recruiting | 2 | 142 | RoW | Fluzoparib+Apatinib, Fluzoparib | Jiangsu HengRui Medicine Co., Ltd. | Relapsed Ovarian Cancer | 03/22 | 03/22 | | |
NCT05489926: A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure |
|
|
| Active, not recruiting | 2 | 15 | RoW | Pamiparib | Zhejiang Cancer Hospital | Epithelial Ovarian Cancer | 06/24 | 12/24 | | |
NCT04590599: A Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy |
|
|
| Completed | 2 | 205 | RoW | IBI310, Placebo, Sintilimab, IBI308 | Innovent Biologics (Suzhou) Co. Ltd. | Advanced Cervical Cancer | 11/23 | 11/23 | | |
NCT06434610: A Study of B013 in Combination With Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer. |
|
|
| Recruiting | 2 | 90 | RoW | B013, Paclitaxel, Placebo | Shanghai Jiaolian Drug Research and Development Co., Ltd, Shanghai Pharmaceuticals Holding Co., Ltd | Platinum-resistant Recurrent Ovarian Cancer | 12/26 | 12/26 | | |
BGB-A317-2007, NCT05247619: A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer |
|
|
| Recruiting | 2 | 49 | RoW | Tislelizumab / Bevacizumab/Paclitaxel/Cisplatin/Carboplatin | Zhejiang Cancer Hospital | Cervical Cancer | 08/24 | 01/25 | | |
| Recruiting | 1 | 170 | RoW | SPH7485 | Shanghai Pharmaceuticals Holding Co., Ltd | Advanced Solid Tumor | 12/27 | 12/27 | | |
